Back to Search
SHAMSHA DORAN, MD
MD
Neurology Physician
NPI: 1508065947IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical Neurophysiology Physician
Psychiatry & Neurology — Clinical Neurophysiology
Code: 2084N0600X
A90583(CA)
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
A90583(CA)
CMS Specialties
PrimaryNEUROLOGY
Education
OTHER
Class of 2003
Research & Publications (20)
The history and principles of chemical dosimetry for 3-D radiation fields: gels, polymers and plastics.
PMID 18675549·Appl Radiat Isot·2009
6-review
Roles of Ca2+ and protein kinase C in the excitatory response to serotonin in embryonic molluscan ciliary cells.
PMID 16900248·Can J Physiol Pharmacol·2006
7-preclinical
Sleep and developmental disabilities: assessment, treatment, and outcome measures.
PMID 16405384·Ment Retard·2006
6-review
Effect of serotonin on ciliary beating and intracellular calcium concentration in identified populations of embryonic ciliary cells.
PMID 15010492·J Exp Biol·2004
4-observational
Constitutive and permissive roles of nitric oxide activity in embryonic ciliary cells.
PMID 12676758·Am J Physiol Regul Integr Comp Physiol·2003
7-preclinical
Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure.
PMID 19596018·Neuropharmacology·2010
7-preclinical
The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy.
PMID 19603478·Cancer·2009
4-observational
Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists.
PMID 19346127·Bioorg Med Chem Lett·2009
7-preclinical
Effects of vas deferens obstruction on Cajal-like cells in rats.
PMID 19641366·Urol Int·2009
7-preclinical
Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n,n-disubstituted-1,4-diazepane scaffold that promotes sleep in rats.
PMID 19418500·ChemMedChem·2009
7-preclinical
Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in mice.
PMID 19451696·J Clin Invest·2009
7-preclinical
Piperidinyl-2-phenethylamino inhibitors of DPP-IV for the treatment of type 2 diabetes.
PMID 19285862·Bioorg Med Chem Lett·2009
4-observational
Dosimetry of the microSelectron-HDR Ir-192 source using PRESAGE and optical CT.
PMID 18684629·Appl Radiat Isot·2009
8-other
(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitor.
PMID 19275964·Bioorg Med Chem Lett·2009
7-preclinical
Positive allosteric interaction of structurally diverse T-type calcium channel antagonists.
PMID 19582593·Cell Biochem Biophys·2009
7-preclinical
A preliminary analysis of LET effects in the dosimetry of proton beams using PRESAGE and optical CT.
PMID 18691895·Appl Radiat Isot·2009
8-other
Integrative biology of an embryonic respiratory behaviour in pond snails: the 'embryo stir-bar hypothesis'.
PMID 18490388·J Exp Biol·2008
6-review
Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist.
PMID 18540666·J Med Chem·2008
7-preclinical
Mitigation of chlorine-induced lung injury by low-molecular-weight antioxidants.
PMID 18708632·Am J Physiol Lung Cell Mol Physiol·2008
7-preclinical
Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
PMID 18817368·J Med Chem·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1801 WILSHIRE BLVD STE 100
SANTA MONICA, CA 90403 - Phone
- (310) 319-5098
Quick Facts
- NPI
- 1508065947
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile